
-
Trump says 'on the same side of every issue' with Netanyahu after call
-
ECB's Lagarde hopes Trump won't fire US Fed chief Powell
-
Gold hits record as Trump fuels Fed fears, Wall Street rebounds
-
The world leaders set to attend Francis's funeral
-
East Timor mourns Pope Francis months after emotional visit
-
US envoy to visit Moscow as US pushes for ceasefire
-
At least 24 killed in Kashmir attack on tourists: Indian police source
-
Philippine typhoon victims remember day Pope Francis brought hope
-
IMF slashes global growth outlook on impact of Trump tariffs
-
BASF exits Xinjiang ventures after Uyghur abuse reports
-
Nordics, Lithuania plan joint purchase of combat vehicles
-
Gold hits record, stocks diverge as Trump fuels Fed fears
-
World could boost growth by reducing trade doubt: IMF chief economist
-
IMF slashes global growth outlook on impact of US tariffs
-
IMF slashes China growth forecasts as trade war deepens
-
Skipper Shanto leads Bangladesh fightback in Zimbabwe Test
-
US VP Vance says 'progress' in India trade talks
-
Ex-England star Youngs to retire from rugby
-
Black Ferns star Woodman-Wickliffe returning for World Cup
-
Kremlin warns against rushing Ukraine talks
-
Mbappe aiming for Copa del Rey final return: Ancelotti
-
US universities issue letter condemning Trump's 'political interference'
-
Pope Francis's unfulfilled wish: declaring PNG's first saint
-
Myanmar rebels prepare to hand key city back to junta, China says
-
Hamas team heads to Cairo for Gaza talks as Israel strikes kill 26
-
Pianist to perform London musical marathon
-
India's Bumrah, Mandhana win top Wisden cricket awards
-
Zurab Tsereteli, whose monumental works won over Russian elites, dies aged 91
-
Roche says will invest $50 bn in US, as tariff war uncertainty swells
-
Pope Francis's funeral set for Saturday, world leaders expected
-
US official asserts Trump's agenda in tariff-hit Southeast Asia
-
World leaders set to attend Francis's funeral as cardinals gather
-
Gold hits record, stocks mixed as Trump fuels Fed fears
-
Roche says will invest $50 bn in US over next five years
-
Fleeing Pakistan, Afghans rebuild from nothing
-
US Supreme Court to hear case against LGBTQ books in schools
-
Pistons snap NBA playoff skid, vintage Leonard leads Clippers
-
Migrants mourn pope who fought for their rights
-
Duplantis kicks off Diamond League amid Johnson-led changing landscape
-
Taliban change tune towards Afghan heritage sites
-
Kosovo's 'hidden Catholics' baptised as Pope Francis mourned
-
Global warming is a security threat and armies must adapt: experts
-
Can Europe's richest family turn Paris into a city of football rivals?
-
Climate campaigners praise a cool pope
-
As world mourns, cardinals prepare pope's funeral
-
US to impose new duties on solar imports from Southeast Asia
-
Draft NZ law seeks 'biological' definition of man, woman
-
Auto Shanghai to showcase electric competition at sector's new frontier
-
Tentative tree planting 'decades overdue' in sweltering Athens
-
Indonesia food plan risks 'world's largest' deforestation

WHO countries strike landmark agreement on tackling future pandemics
Years of negotiations culminated early Wednesday with countries agreeing the text of a landmark accord on how to tackle future pandemics, aimed at avoiding the mistakes made during the Covid-19 crisis.
After more than three years of talks and one last marathon session, weary delegates at the World Health Organization's headquarters finally sealed the deal at around 2:00 am (0000 GMT) Wednesday.
"Tonight marks a significant milestone in our shared journey towards a safer world," said WHO chief Tedros Adhanom Ghebreyesus.
"The nations of the world made history in Geneva today."
Five years after the emergence of Covid-19, which killed millions of people, devastated economies and upturned health systems, a sense of urgency hung over the talks, with new threats lurking -- including H5N1 bird flu, measles, mpox and Ebola.
The final stretch of the talks also took place under the shadow of cuts to US foreign aid spending and threatened tariffs on pharmaceuticals.
- 'It's adopted' -
Right until the last minute, disagreement lingered over a few thorny issues.
Negotiators stumbled over the agreement's Article 11, which deals with transferring technology for pandemic health products towards developing nations.
During the Covid-19 pandemic, poorer states accused rich nations of hoarding vaccines and tests.
Countries with large pharmaceutical industries have strenuously opposed the idea of mandatory tech transfers, insisting they must be voluntary.
But it appeared the obstacle could be overcome by adding that any transfer needed to be "mutually agreed".
The core of the agreement is a proposed Pathogen Access and Benefit-Sharing System (PABS), aimed at allowing the swift sharing of pathogen data with pharmaceutical companies, enabling them to quickly start working on pandemic-fighting products.
In the end, the 32-page agreement was entirely highlighted in green, indicating all of it had been fully approved by WHO member states.
"It's adopted," negotiations co-chair Anne-Claire Amprou announced, to thunderous applause.
"In drafting this historic agreement, the countries of the world have demonstrated their shared commitment to preventing and protecting everyone, everywhere, from future pandemic threats."
The finalised text will now be presented for sign-off at the WHO's annual assembly next month.
- 'More equity' -
As intense talks in corridors and closed rooms drew towards an end late on Tuesday, Tedros told reporters he thought the draft was "balanced", and that a deal would bring "more equity".
While taking measures to coordinate pandemic prevention, preparedness and response could be costly, "the cost of inaction is much bigger", he insisted.
"Virus is the worst enemy. (It) could be worse than a war."
The United States, which has thrown the global health system into crisis by slashing foreign aid spending, was absent.
US President Donald Trump ordered a withdrawal from the United Nations' health agency and from the pandemic agreement talks after taking office in January.
However, the US absence, and Trump's threat to slap steep tariffs on pharmaceutical products, still hung over the talks, making manufacturers and governments more jittery.
But in the end, countries reached consensus.
- 'Real work begins now' -
Looking ahead towards implementation, the leading pharma lobby said intellectual property and legal certainty would be essential if the industry was to invest in high-risk research and development in the next crisis.
"The pandemic agreement is a starting point," said David Reddy, director general of the International Federation of Pharmaceutical Manufacturers and Associations, which participated in the talks.
"We hope that in subsequent negotiations, member states maintain the conditions for the private sector to continue innovating against pathogens of pandemic potential."
Many saw the approval of the text as a victory for global cooperation.
"At a time when multilateralism is under threat, WHO member states have joined together to say that we will defeat the next pandemic threat in the only way possible: by working together," said New Zealand's former prime minister Helen Clark, co-chair of the Independent Panel for Pandemic Preparedness and Response.
As the congratulatory speeches continued on towards daybreak at the WHO HQ, Eswatini's representative cautioned that "whilst we celebrate this moment, we need not rest on our laurels.
"The real work begins now."
A.Moore--AT